Betz Stephen F. 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jul 26, 2024
Insider Transaction Report
Form 4
Betz Stephen F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-07-25$53.43/sh−3,000$160,290→ 75,611 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $53.43 per share. The range of sales prices on the transaction date was $53.41 to $53.45 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.